ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

ישראל - עברית - Ministry of Health

j-c health care ltd - guselkumab - תמיסה להזרקה - guselkumab 100 mg / 1 ml - guselkumab

ישראל - עברית - Ministry of Health

rafa laboratories ltd - midazolam - תמיסה להזרקה - midazolam 1 mg/ml - midazolam - midazolam - premedication before induction of anesthesia (i.m). basal sedation before diagnostic or surgical interventions carried out under local anesthesia (i.v. administration). induction and maintenance of anesthesia. as an induction agent in inhalation anesthesia or a sleep-inducing component in combined anesthesia, including total intravenous anesthesia (i.v. injection, i.v. infusion). ataralgesia in combination with ketamine in children (i.m. administration). status epilepticus.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - midazolam - תמיסה להזרקה - midazolam 5 mg/ml - midazolam - midazolam - premedication befor induction of anesthesia (i.m). basal sedation before diagnostic or surgical interventions carried out under local anesthesia (i.v. administration). induction and maintenance of anesthesia. as an induction agent in inhalation anesthesia or a sleep-inducing component in combined anesthesia, including total intravenous anesthesia (i.v. injection, i.v. infusion). ataralgesia in combination with ketamine in children (i.m. administration).status epilepticus.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - medetomidine hydrochloride 1 mg/ml - solution for injection - dogs:for restraint, sedation and analgesia associated with clinical examinations and procedures, minor surgery and pre-anaesthesia.as a premedicant before thiopentone, halothane general anaesthesia and as a premedicant before general anaesthesia with propofol.cats:for restraint and sedation.in combination with ketamine for induction of general anaesthesia prior to surgical procedures.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - dexmedetomidine hydrochloride 0.5 mg/ml - solution for injection - non-invasive mildly to moderately painful procedures and examinations which require restraint sedation and analgesia in dogs and cats. premedication in cats before induction and maintenance of general anaesthesia with ketamine. deep sedation and analgesia in dogs in concomitant use with butorphanol for medical and minor surgical procedures. premedication in dogs before induction and maintenance of general anaesthesia.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - cabergoline - טבליה - cabergoline 0.5 mg - cabergoline - cabergoline - treatment of hyperprolactinemic disorders.dostinex is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. dostinex is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. inhibition and supression of lactation .